These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7586530)

  • 21. Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus.
    Dunseath G; Ananieva-Jordanova R; Coles R; Powell M; Amoroso M; Furmaniak J; Smith BR; Dayan C; Luzio S
    Clin Chim Acta; 2015 Jul; 447():90-5. PubMed ID: 26006309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Autoantibodies to glutamate decarboxylase in children with newly detected insulin-dependent diabetes mellitus].
    Trofimenko EV; Zlobina EV; Lebedev NV; Martynova MI; Piliutik VF; Shchegol'kova TS; Zlobina EN; Dedov II
    Probl Endokrinol (Mosk); 1994; 40(2):18-21. PubMed ID: 8197083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes.
    Beischer NA; Wein P; Sheedy MT; Mackay IR; Rowley MJ; Zimmet P
    Am J Obstet Gynecol; 1995 Nov; 173(5):1563-9. PubMed ID: 7503202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies predicting diabetes mellitus type I in celiac disease.
    Galli-Tsinopoulou A; Nousia-Arvanitakis S; Dracoulacos D; Xefteri M; Karamouzis M
    Horm Res; 1999; 52(3):119-24. PubMed ID: 10725775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme-linked immunosorbent assay.
    Murata T; Tsuzaki K; Nirengi S; Watanabe T; Mizutani Y; Okada H; Tsukamoto M; Odori S; Nakagawachi R; Kawaguchi Y; Yoshioka F; Yamada K; Shimatsu A; Kotani K; Satoh-Asahara N; Sakane N
    J Diabetes Investig; 2017 Jul; 8(4):475-479. PubMed ID: 27863109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin-GAD65 fusion protein.
    Luo D; Rogers CN; Steed JT; Gilliam LK; Hampe CS; Lernmark A
    J Biotechnol; 2004 Jul; 111(1):97-104. PubMed ID: 15196774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmunoprecipitation assay for glutamic acid decarboxylase antibodies evaluated clinically with sera from patients with insulin-dependent diabetes mellitus.
    Ohta M; Obayashi H; Takahashi K; Kitagawa Y; Nakano K; Matsuo S; Nishimura M; Itoh N; Ohta K
    Clin Chem; 1996 Dec; 42(12):1975-8. PubMed ID: 8969635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of anti-glutamic acid decarboxylase and anti-thyroperoxidase autoantibodies in siblings of patients with diabetes diagnosed in adult life.
    Rosário PW; Reis JS
    Int J Clin Pract; 2009 Mar; 63(3):517. PubMed ID: 19222639
    [No Abstract]   [Full Text] [Related]  

  • 30. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
    Thivolet C
    Journ Annu Diabetol Hotel Dieu; 1992; ():165-71. PubMed ID: 1495236
    [No Abstract]   [Full Text] [Related]  

  • 32. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus.
    Bingley PJ; Bonifacio E; Gale EA
    Lancet; 1994 Jul; 344(8917):266-7. PubMed ID: 7913179
    [No Abstract]   [Full Text] [Related]  

  • 34. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age.
    Lindberg B; Ivarsson SA; Landin-Olsson M; Sundkvist G; Svanberg L; Lernmark A
    Diabetologia; 1999 Feb; 42(2):181-7. PubMed ID: 10064098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The study of two immunological markers in patients with type-1 diabetes and in their first degree relatives].
    Cosmescu A; Graur M; Zlei M; Mătăsaru S; Felea D; Petroaie A; Slanină AM; Barbacariu L; Momanu O
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):549-53. PubMed ID: 15832972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of glutamic acid decarboxylase autoantibodies in Mexican diabetic children.
    Mendoza-Morfín F; Curiel-Pérez MO; Cárdenas-Tirado H; Montero-González P; Gutiérrez-Avila C; Bravo-Ríos LE; Cárdenas-Cornejo I; Normandía-Almeida MA
    Rev Invest Clin; 2000; 52(4):427-31. PubMed ID: 11061105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Latent autoimmune diabetes and limbic encephalitis with antibodies against glutamic acid decarboxylase.
    Popkirov S; Sebastian S; Ismail FS; Wellmer J
    J Diabetes; 2018 Apr; 10(4):338-340. PubMed ID: 29154389
    [No Abstract]   [Full Text] [Related]  

  • 38. Glutamic acid decarboxylase antibodies and diabetes complications. Assay reliability and validity.
    Lernmark A
    Diabetes Care; 1995 Feb; 18(2):269-71. PubMed ID: 7729309
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoantibodies to IA-2 in type 1 diabetes: measurements with a new enzyme-linked immunosorbent assay.
    Kawasaki E; Yamaguchi H; Hattori H; Egashira T; Eguchi K
    Ann N Y Acad Sci; 2002 Apr; 958():241-6. PubMed ID: 12021115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
    Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
    Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.